Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ
Zmień bibliotekę

Wyszukujesz frazę ""COVID-19 therapy"" wg kryterium: Temat


Tytuł :
Doxycycline in the Coronavirus Disease 2019 Therapy
Autorzy :
Dorobisz K
Dorobisz T
Janczak D
Zatoński T
Pokaż więcej
Temat :
covid-19
covid-19 therapy
doxycycline
sars-cov-2
Medicine (General)
R5-920
Źródło :
Therapeutics and Clinical Risk Management, Vol Volume 17, Pp 1023-1026 (2021)
Opis pliku :
electronic resource
Relacje :
https://www.dovepress.com/doxycycline-in-the-coronavirus-disease-2019-therapy-peer-reviewed-fulltext-article-TCRM; https://doaj.org/toc/1178-203X
Dostęp URL :
https://doaj.org/article/67750291f4de4589a94402750e56b5e8
Czasopismo naukowe
Tytuł :
MSC-derived exosomes carrying a cocktail of exogenous interfering RNAs an unprecedented therapy in era of COVID-19 outbreak
Autorzy :
Monire Jamalkhah
Yasaman Asaadi
Mohammadreza Azangou-Khyavy
Javad Khanali
Masoud Soleimani
Jafar Kiani
Ehsan Arefian
Pokaż więcej
Temat :
Mesenchymal stem cells
COVID-19
SARS-CoV-2
Exosomes
RNA interference
COVID-19 therapy
Medicine
Źródło :
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-15 (2021)
Opis pliku :
electronic resource
Relacje :
https://doaj.org/toc/1479-5876
Dostęp URL :
https://doaj.org/article/d1ac2f28ca774bf1bced4a173fcae465
Czasopismo naukowe
Tytuł :
Anti-SARS-CoV-2 Strategies and the Potential Role of miRNA in the Assessment of COVID-19 Morbidity, Recurrence, and Therapy
Autorzy :
Maria Narożna
Błażej Rubiś
Pokaż więcej
Temat :
coronavirus
SARS-CoV-2
COVID-19
miRNA
miR
COVID-19 therapy
Biology (General)
QH301-705.5
Chemistry
QD1-999
Źródło :
International Journal of Molecular Sciences, Vol 22, Iss 8663, p 8663 (2021)
Opis pliku :
electronic resource
Relacje :
https://www.mdpi.com/1422-0067/22/16/8663; https://doaj.org/toc/1661-6596; https://doaj.org/toc/1422-0067
Dostęp URL :
https://doaj.org/article/808df11c200941c0a05690c0e3a71a7d
Czasopismo naukowe
Tytuł :
Molecular features of non-selective small molecule antagonists of the Bradykinin receptors
Autorzy :
Rasaeifar, Bahareh
Gómez Gutierrez, Patricia
Pérez González, Juan Jesús
Pokaż więcej
Temat :
Àrees temàtiques de la UPC::Enginyeria química
COVID-19 (Disease)
Bradykinin receptors
Bradykinin pharmacophore
Non-peptide bradykinin antagonists
Bradykinin repurposing
Covid-19 therapy
COVID-19 (Malaltia)
Molècules
Opis pliku :
application/pdf
Relacje :
https://www.mdpi.com/1424-8247/13/9/259; Rasaeifar, B.; Gomez-Gutierrez, P.; Perez, J. Molecular features of non-selective small molecule antagonists of the Bradykinin receptors. "Pharmaceuticals", 21 Setembre 2020, vol. 13, núm. 9, p. 259:1-259:10.; http://hdl.handle.net/2117/334784
Dostępność :
https://doi.org/10.3390/ph13090259
http://hdl.handle.net/2117/334784
Czasopismo naukowe
Tytuł :
Considerations for patients with cardiovascular diseases during the COVID-19 pandemic ; Consideraciones para pacientes con enfermedades cardiovasculares durante la pandemia de la COVID-19
Autorzy :
Alfonso Rodríguez, Emilio
Llerena Rojas, Lorenzo Daniel
Rodriguez Nande, Lidia Maria
Pokaż więcej
Temat :
coronavirus
cardiovascular therapy
COVID-19 therapy
terapia cardiovascular
terapia COVID-19
Źródło :
Revista Cubana de Investigaciones Biomédicas; Vol. 39, No. 3 (2020): Julio-Septiembre ; 1561-3011 ; 0864-0300
Opis pliku :
application/pdf
Relacje :
http://www.revibiomedica.sld.cu/index.php/ibi/article/view/795/734;">http://www.revibiomedica.sld.cu/index.php/ibi/article/view/795/734; Huang C, Wang Y, Li X, Lili R, Jianping Z, Yi H, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497-506. Available from: https://doi.org/10.1016/S0140-6736(20)30183-5; World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 Marzo 2020. Disponible en : https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-themedia-briefing-on-covid-19---11-march-2020 ( consultado 08 de abril del 2020). 3. 1. Driggin E, Madhavan M V, Bikdeli B, Chuich T, Laracy J, Biondi-Zoccai G, et al.; Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic. J Am Coll Cardiol [Internet]. 2020 May 12;75(18):2352 LP – 2371. Available from: 10.1016/j.jacc.2020.03.031; Biondi Zoccai G, Landoni G, Carnevale R, Cavarretta E, Sciarretta R, Frati G. SARSCoV-2 amd COVID-19: facing the pandemic together as citizens and cardiovascular practitioners. Minerva Cardioangiol 2020;68:61-4. Available from: 10.23736/S0026-4725.20.05250-0; Li B, Yang J, Zhao F et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol 2020. May;109(5):531-538. Available from: http://10.1007/s00392-020-01626-9; Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. NatRev Cardiol 2020. May;17(5):259-260. Available from: http://10.1038/s41569-020-0360- 5; Zhou F, Yu T, Du R, Guohui F, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020. Mar 28;395(10229):1054-1062. Available from: http://10.1016/S0140-6736(20)30566-3 .; Su S, Wong G, Shi W, Liu J, Lai ACK, Zhou J, et al. Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses. Trends Microbiol 2016;24:490-502. Available from: https://doi.org/10.1016/j.tim.2016.03.003; Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020. Mar;579(7798):270-273. Available from: http://10.1038/s41586-020-2012-7; Ge X-Y, Li J-L, Yang X-L, Chmura AA, Zhu G, Epstein JH, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature 2013;503:535-8.; Wang H, Yang P, Liu K, Guo F, Zhang Y, Zhang G, et al. SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway. Cell Res 2008;18:290-301. Available from: https://doi.org/10.1038/cr.2008.15; Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med [Internet]. 2020;46(4):586–90. Available from: https://doi.org/10.1007/s00134-020-05985-9; World Health Organization. Coronavirus Disease 2019 (COVID-19). Disponible en : https://www.who.int/docs/defaultsource/coronaviruse/situation-reports/20200424 ( consultado 24 de abril del 2020).; Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239- 1242. Available from: http://10.1001/jama.2020.2648; Marta Albalate, Arribas E, Torres M. Cintra R, Alcázar M, Puerta M, et al. Alta prevalencia de covid19 asintomático en hemodiálisis. Aprendiendo día a día el primer mes de pandemia de covid19. Disponible en: https://doi.org/doi:10.1016/j.nefro.2020.04.005. (consultado 06 de junio del 2020).; Li LQ, Huang T, Wang YQ, Zheng-ping W, Yuan L, Tao-bi H, et al. 2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of metaanalysis. J Med Virol 2020. Mar 12. Available from: http://10.1002/jmv.25757; Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA 2020. Feb 7. Available from: http://10.1001/jama.2020.1585.; Murthy S, Gomersall CD, Fowler RA. Care for Critically Ill Patients With COVID-19. JAMA [Internet]. 2020 Apr 21;323(15):1499–500. Available from: https://doi.org/10.1001/jama.2020.3633; Chen N, Zhou M, Dong X et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020;395:507-513.; Liu K, Fang Y-Y, Deng Y, Liu W, Wang M-F, Ma J-P, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J (Engl) [Internet]. 2020;133(9). Available from: http://10.1097/CM9.0000000000000744; Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. Published online March 13, 2020. Available from: https://doi.org/10.1001/jamainternmed.2020.0994; Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med [Internet]. 2020 Feb 28;382(18):1708– 20. Available from: https://doi.org/10.1056/NEJMoa2002032; Zidar DA, Al-Kindi SG, Liu Y, Krieger NI, Perzynski AT, Osnard M, et al. Association of Lymphopenia With Risk of Mortality Among Adults in the US General Population. JAMA Netw Open [Internet]. 2019 Dec 2;2(12):e1916526–e1916526. Available from: https://doi.org/10.1001/jamanetworkopen.2019.16526; Kwong JC, Schwartz KL, Campitelli MA. Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection. N Engl J Med [Internet]. 2018 Jun 27;378(26):2538–41. Available from: https://doi.org/10.1056/NEJMc1805679; Davis MM, Taubert K, Benin AL. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol 2006;48:1498-502.; Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med [Internet]. 2020;46(5):846–8. Available from: https://doi.org/10.1007/s00134020-05991-x; Sarkisian L, Saaby L, Poulsen TS. Clinical Characteristics and Outcomes of Patients with Myocardial Infarction, Myocardial Injury, and Nonelevated Troponins. Am J Med 2016;129:446 e5-446 e21.; Thygesen K, Alpert JS, Jaffe AS. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol 2018;72:2231-64.; Yang X, Yu Y, Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020. Feb 24. pii: S2213-2600(20)30079-5. Available from: http://10.1016/S2213-2600(20)30079-5; Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis 2020. Mar 10. pii: S0033-0620(20)30055-4. Available from: http://10.1016/j.pcad.2020.03.001; Xu Z, Shi L, Wang Y. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020. Apr;8(4):420-22. Available from: http://10.1016/S2213-2600(20)30076-X; Liu Y, Yang Y, Zhang C. Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci 2020;63:364-374.; Behnood B, Mahesh V, David J, Taylor Ch, Isaac Dreyfus, Elissa D, et al.COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up. Journal of the American College of Cardiology.Volume 75, Issue 23, June 2020.DOI:10.1016/j.jacc.2020.04.031.; Wood S. TCT the Heat Beat: COVID-19 and the Heart: Insights from the Front Line 12 Marzo 2020. Disponible en: https://www.tctmd.com/news/covid-19-and-heart-insightsfront-lines (Consultado 10, Abril 2020).; Frederick G.P. Welt, MD, Pinak B. Shah, MD, Herbert D. Aronow, MD, et al.Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic: From ACC’s Interventional Council and SCAI. Journal of the American College of Cardiology. S0735-1097(20)34566-6.; Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People’s Hospital. Intensive Care Med [Internet]. 2020;46(6):1111–3. Available from: https://doi.org/10.1007/s00134-020-05993-9; Buzon J, Roignot O, Lemoine S. Takotsubo Cardiomyopathy Triggered by Influenza A Virus. Intern Med 2015;54:2017-9.; Zompatori M, Ciccarese F, Fasano L. Overview of current lung imaging in acute respiratory distress syndrome. Eur Respir Rev 2014;23:519-30.; Ferguson ND, Fan E, Camporota L. The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material. Intensive Care Med 2012;38:1573-82. 41. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, Tan GB, et al. Hematologic parameters in patients with COVID-19 infection. Am J Hematol [Internet]. 2020 Jun 1;95(6):E131–4. Available from: https://doi.org/10.1002/ajh.25774; Tang N, Li D, Wang X, Sun Z. Abnormal Coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020 Apr;18(4):844-847. Available from: http://10.1111/jth.14768; Elfiky AA. Anti-HCV, nucleotide inhibitors, repurposing against COVID-19. Life Sci 2020;248:117477.; KALETRA(R) oral film coated tablets, oral solution, lopinavir ritonavir oral film coated tablets, oral solution. Product Insert. AbbVie Inc. (per FDA), North Chicago, IL, 2013. Disponible en: https://books.google.com.cu/books?hl=es&lr=&id=ETv2DQAAQBAJ&oi=fnd&pg=PA75 &dq=KALETRA(R)+oral+film+coated+tablets,+oral+solution,+lopinavir+ritonavir+oral+ film+coated+tablets,+oral+solution.+Product+Insert.+AbbVie+Inc.+(per+FDA),+North+ Chicago,+IL,+2013.+66.+34.+&ots=A4xd8b9QG9&sig=yPH3vqbA74Tv69vJ7GjsiDj8CI o&redir_esc=y#v=onepage&q&f=false . (Consultado 10 Abril del 2020).; DeCarolis DD, Westanmo AD, Chen YC, Boese AL, Walquist MA, Rector TS. Evaluation of a Potential Interaction Between New Regimens to Treat Hepatitis C and Warfarin. Ann Pharmacother 2016;50:909-917.; Product monograph. Brilinta (ticagrelor). Mississauga, Ontario, Canada: AstraZeneca Canada Inc., May 2011. Disponible en: https://www.canada.ca/en/healthcanada/services/drugs-health-products/medeffect-canada/health-product-infowatch/july2019.html (Consultado 10 Abril del 2020).; Itkonen MK, Tornio A, Lapatto-Reiniluoto O et al. Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel. Clin Pharmacol Ther 2019;105:219-228.; Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020. Mar 16;14(1):72-73. Available from: http://10.5582/bst.2020.01047; Tonnesmann E, Kandolf R, Lewalter T. Chloroquine cardiomyopathy - a review of the literature. Immunopharmacol Immunotoxicol 2013;35:434-42.; Gurwitz D. Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.Drug Dev Res [Internet]. 2020 Mar 4;n/a(n/a). Available from: https://doi.org/10.1002/ddr.21656; http://www.revibiomedica.sld.cu/index.php/ibi/article/view/795
Dostępność :
https://doi.org/10.1016/S0140-6736(20)30183-5
https://doi.org/10.1016/j.tim.2016.03.003
https://doi.org/10.1038/cr.2008.15
https://doi.org/10.1007/s00134-020-05985-9
https://doi.org/10.1016/j.nefro.2020.04.005
https://doi.org/10.1001/jama.2020.3633
https://doi.org/10.1001/jamainternmed.2020.0994
https://doi.org/10.1056/NEJMoa2002032
https://doi.org/10.1001/jamanetworkopen.2019.16526
https://doi.org/10.1056/NEJMc1805679
Czasopismo naukowe
Tytuł :
Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
Autorzy :
Valentino Clemente
Padraig D’Arcy
Martina Bazzaro
Pokaż więcej
Temat :
DUBs
coronavirus
SARS
SARS-CoV2
papain-like protease
PLP inhibitors
COVID-19
COVID-19 therapy
Źródło :
International Journal of Molecular Sciences ; Volume 21 ; Issue 10
Opis pliku :
application/pdf
Relacje :
Biochemistry; http://dx.doi.org/10.3390/ijms21103492
Dostępność :
https://doi.org/10.3390/ijms21103492
Czasopismo naukowe
Tytuł :
An experience of using Laennec in patients at high risk of a cytokine storm with COVID-19 and hyperferritinemia ; Опыт применения препарата Лаеннек у пациентов с высоким риском развития «цитокинового шторма» на фоне COVID-19 и гиперферритинемии
Autorzy :
V. Maksimov A.
I. Torshin Yu.
A. Chuchalin G.
L. Lazebnik B.
O. Tkacheva N.
I. Strazhesko D.
O. Gromova A.
В. Максимов А.
И. Торшин Ю.
А. Чучалин Г.
Л. Лазебник Б.
О. Ткачева Н.
И. Стражеско Д.
О. Громова А.
Pokaż więcej
Temat :
COVID-19 therapy
comorbid conditions
ferritinemia
Laennec
predictive modeling
intellectual data analysis
терапия COVID-19
коморбидные состояния
ферритинемия
Лаеннек
предиктивное моделирование
интеллектуальный анализ данных
Źródło :
PULMONOLOGIYA; Том 30, № 5 (2020); 587-598 ; Пульмонология; Том 30, № 5 (2020); 587-598 ; 2541-9617 ; 0869-0189 ; 10.18093/0869-0189-2020-30-5
Opis pliku :
application/pdf
Relacje :
https://journal.pulmonology.ru/pulm/article/view/1356/1756;">https://journal.pulmonology.ru/pulm/article/view/1356/1756; Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemost. 2020; 18 (4): 844–847. DOI:10.1111/jth.14768.; Liu C., Jiang Z.C., Shao C.X. et al. [Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study]. Zhonghua Gan Zang Bing Za Zhi. 2020; 28 (2): 148–152. DOI:10.3760/cma.j.issn.1007-3418.2020.02.003 (in Chinese).; Громова О.А., Торшин И.Ю. Важность цинка для поддержания активности белков врожденного противовирусного иммунитета: анализ публикаций, посвященных COVID-19. Профилактическая медицина. 2020; 23 (3): 131–139. DOI:10.17116/profmed202023031131.; Стефанюк О.В., Лазебник Л.Б. Поражения органов пищеварения при инфицировании SARS-CoV-2. Экспериментальная и клиническая гастроэнтерология. 2020; 175 (3): 4–9. DOI:10.31146/1682-8658-ecg-175-3-4-9.; Jin X., Lian J.S., Hu J.H. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69 (6): 1002–1009. DOI:10.1136/gutjnl-2020-320926.; Торшин И.Ю., Громова О.А. Мировой опыт использования гидролизатов плаценты человека в терапии. Экспериментальная и клиническая гастроэнтерология. 2019; 170 (10): 79–89. DOI:10.31146/1682-8658-ecg-17010-79-89.; Torshin I.Yu., Rudakov K.V. On the theoretical basis of metric analysis of poorly formalized problems of recognition and classification. Pattern Recognit. Image Anal. 2015; 25 (4): 577–587. DOI:10.1134/s1054661815040252.; Torshin I.Yu., Rudakov K.V. Topological data analysis in materials science: the case of high-temperature cuprate superconductors. Pattern Recognit. Image Anal. 2020; 30 (2): 264–276. DOI:10.1134/S1054661820020157.; Torshin I.Yu., Rudakov K.V. On the procedures of generation of numerical features over partitions of sets of objects in the problem of predicting numerical target variables. Pattern Recognit. Image Anal. 2019; 29 (4): 654–667. DOI:10.1134/S1054661819040175.; Громова О.А., Торшин И.Ю., Кобалава Ж.Д. и др. Дефицит магния и гиперкоагуляционные состояния: метрический анализ данных выборки пациентов 1850 лет лечебно-профилактических учреждений России. Кардиология. 2018; 58 (4): 22–35. DOI:10.18087/cardio.2018.4.10106.; Торшин И.Ю., Громова О.А., Тетруашвили Н.К. и др. Метрический анализ соотношений коморбидности между невынашиванием, эндометриозом, нарушениями менструального цикла и микронутриентной обеспеченностью в скрининге женщин репродуктивного возраста. Акушерство и гинекология. 2019; (5): 160–173. DOI:10.18565/aig.2019.5.; Chen C., Chen C., Yan J.T. et al. [Analysis of myocardial injury in patients with COVID-19 and association between concomitant cardiovascular diseases and severity of COVID19]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020; 48 (7): 567–571. DOI:10.3760/cma.j.cn112148-20200225-00123 (in Chinese).; Henry B.M., de Oliveira M.H.S., Benoit S., Plebani M. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin. Chem. Lab. Med. 2020; 58 (7): 1021–1028. DOI:10.1515/cclm-2020-0369.; Zeng F., Huang Y., Guo Y. et al. Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int. J. Infect. Dis. 2020; 96: 467–474. DOI:10.1016/j.ijid.2020.05.055.; Li L.Q., Huang T., Wang Y.Q. et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J. Med. Virol. 2020; 92 (6): 577–583. DOI:10.1002/jmv.25757.; Торшин И.Ю., Громова О.А., Диброва Е.А. и др. Пептиды в составе препарата Лаеннек, потенцирующие его антивирусные эффекты в лечении атопического дерматита герпетической инфекции. Российский аллергологический журнал. 2018; 15 (1–1): 82–90. DOI:10.36691/rja191.; Cheng Y., Luo R., Wang K. et al. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020; 97 (5): 829–838. DOI:10.1016/j.kint.2020,03.005.; Feng G., Zheng K.I., Yan Q.Q. et al. COVID-19 and liver dysfunction: current insights and emergent therapeutic strategies. J. Clin. Transl. Hepatol. 2020; 8 (1): 18–24. DOI:10.14218/JCTH.2020.00018.; Johnson C.A., Levey A.S., Coresh J. et al. Clinical practice guidelines for chronic kidney disease in adults: Part II. Glomerular filtration rate, proteinuria, and other markers. Am. Fam. Physician. 2004; 70 (6): 1091–1097.; Егорова Е.Ю., Торшин И.Ю., Громова О.А., Мартынов А.И. Применение кардиоинтервалографии для скрининговой диагностики и оценки эффективности коррекции дефицита магния и коморбидных ему состояний. Терапевтический архив. 2015; 87 (8): 16–28. DOI:10.17116/terarkh201587816-28.; Громова О.А., Торшин И.Ю., Волков А.Ю. и др. Препарат Лаеннек: элементный состав и фармакологическое действие. Пластическая хирургия и косметология. 2011; (2): 327–333.; https://journal.pulmonology.ru/pulm/article/view/1356
Dostępność :
https://doi.org/10.18093/0869-0189-2020-30-5-587-598
https://doi.org/10.18093/0869-0189-2020-30-5
https://doi.org/10.1111/jth.14768
https://doi.org/10.3760/cma.j.issn.1007-3418.2020.02.003
https://doi.org/10.17116/profmed202023031131
https://doi.org/10.31146/1682-8658-ecg-175-3-4-9
https://doi.org/10.1136/gutjnl-2020-320926
https://doi.org/10.31146/1682-8658-ecg-17010-79-89
https://doi.org/10.1134/s1054661815040252
https://doi.org/10.1134/S1054661820020157
Czasopismo naukowe
Tytuł :
Molecular Features of Non-Selective Small Molecule Antagonists of the Bradykinin Receptors
Autorzy :
Bahareh Rasaeifar
Patricia Gomez-Gutierrez
Juan J. Perez
Pokaż więcej
Temat :
bradykinin receptors
bradykinin pharmacophore
non-peptide bradykinin antagonists
bradykinin repurposing
Covid-19 therapy
Medicine
Pharmacy and materia medica
RS1-441
Źródło :
Pharmaceuticals, Vol 13, Iss 259, p 259 (2020)
Opis pliku :
electronic resource
Relacje :
https://www.mdpi.com/1424-8247/13/9/259; https://doaj.org/toc/1424-8247
Dostęp URL :
https://doaj.org/article/56cddc8380ac4b78aef84e0b7ab4c8f8
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies